ATAI AtaiBeckley Inc. - Common Stock
$7,27
Kurs · Aug 18, 2026
Fundamentaldaten per Nov 12, 2025
52W-Spanne
$3–$7
100% of range
Analystenbewertung
HOLD
21 analysts
Kursziel
$10
+32% upside
P/E (TTM)
-7.8
ROE
-83.1%
Nettogewinnmarge
-48464.0%
ATAI Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.26
Marktkapitalisierung
$1.22B
P/E (TTM)
-7.8
EPS (TTM)
$-0.93
Umsatz (TTM)
$308.0K
Dividendenrendite
—
ROE
-83.1%
Verschuldungsgrad
0.4
52W-Spanne
$3 – $7
ATAI Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$308.0K
2020-12-31
→
2024-12-31
EPS
$-0.93
2021-12-31
→
2024-12-31
Freier Cashflow
$-82M
2021-12-31
→
2024-12-31
Margen
-48464.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ATAI
Peer-Median
P/E (TTM)
-7.8
29.7
P/S (TTM) (K/V (TTM))
3961.8
4.9
P/B (K/B)
10.5
5.5
EV / EBITDA
-12.3
—
Price / FCF (Kurs / FCF)
-14.8
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ATAI
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-33341.2%
—
Net Profit Margin (Nettogewinnmarge)
-48464.0%
-3.7%
ROA
-65.9%
-5.5%
ROE
-83.1%
-22.7%
ROIC
-61.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ATAI
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.4
0.0
Current Ratio (Liquiditätsgrad)
3.2
3.7
Quick Ratio
0.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ATAI
Peer-Median
Revenue YoY (Umsatz YoY)
-1.9%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-75.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ATAI
Peer-Median
ATAI Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
21 Analysten
- Starker Kauf 3 14,3%
- Kauf 6 28,6%
- Halten 12 57,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-13
Median
$8.50
Mittelwert
$9.59
← Unter allen Zielen
$7.26
Tief
$7.45
Hoch
$16.00
Median-Ziel
$8.50
+17,0%
Mittelwert-Ziel
$9.59
+32,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.08 | $-0.10 | 0.02% |
| 31. Dezember 2025 | $-0.06 | $-0.11 | 0.05% |
| 30. September 2025 | $-0.28 | $-0.12 | -0.16% |
| 30. Juni 2025 | $-0.14 | $-0.12 | -0.02% |
| 31. März 2025 | $-0.15 | $-0.18 | 0.03% |
| 31. Dezember 2024 | $-0.24 | $-0.15 | -0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $308.0K | $314.0K | $233.0K | $20M | $0 | |
| R&D Expense | $400.0K | $2M | $3M | · | · | |
| SG&A Expense | $48M | $64M | $70M | $93M | $81M | |
| Operating Expenses | $103M | $126M | $145M | $156M | $104M | |
| Operating Income | $-103M | $-125M | $-145M | $-136M | $-104M | |
| Interest Expense | · | $3M | $923.0K | · | · | |
| Interest Income | $778.0K | $2M | $548.0K | $205.0K | $71.0K | |
| Other Non-op | $-484.0K | $-189.0K | $-489.0K | $-293.0K | $359.0K | |
| Pretax Income | $-148M | $-39M | $-135M | $-137M | $-102M | |
| Income Tax | $-356.0K | $1M | $6M | $4M | $305.0K | |
| Net Income | $-149M | $-40M | $-152M | $-168M | $-170M | |
| EPS (Basic) | $-0.93 | $-0.25 | $-0.98 | $-1.21 | · | |
| EPS (Diluted) | $-0.93 | $-0.25 | $-0.98 | $-1.21 | · | |
| Shares (Basic) | 160,159,983 | 158,833,785 | 155,719,585 | 138,265,859 | · | |
| Shares (Diluted) | 160,159,983 | 158,833,785 | 155,719,585 | 138,265,859 | · | |
| EBITDA | $-102M | $-125M | $-145M | $-136M | · |
Bilanz 27
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $45M | $191M | $362M | $97M | |
| Prepaid Expense | $8M | $6M | $14M | $12M | $2M | |
| Other Current Assets | $775.0K | $846.0K | $2M | $756.0K | $554.0K | |
| Current Assets | $80M | $186M | $287M | $375M | $100M | |
| PP&E (Net) | $3M | $981.0K | $928.0K | $149.0K | $71.0K | |
| PP&E (Gross) | $3M | $1M | · | · | · | |
| Accum. Depreciation | $398.0K | $153.0K | · | · | · | |
| Goodwill | $331.0K | $0 | · | · | · | |
| Intangibles | $3M | $2M | · | · | · | |
| Other Non-current Assets | $850.0K | $948.0K | $3M | $7M | $339.0K | |
| Total Assets | $159M | $293M | $305M | $414M | $112M | |
| Accounts Payable | $3M | $5M | $2M | $6M | $3M | |
| Accrued Liabilities | $10M | $15M | $17M | $15M | $9M | |
| Short-term Debt | $45M | $109M | $82M | · | · | |
| Current Liabilities | $25M | $20M | $20M | $21M | $12M | |
| Capital Leases | $732.0K | $990.0K | $44.0K | · | · | |
| Other Non-current Liabilities | $3M | $8M | $4M | $4M | $0 | |
| Total Liabilities | $43M | $49M | $40M | $28M | $16M | |
| Long-term Debt | $14M | $15M | $15M | $0 | · | |
| Total Debt | $51M | $109M | $82M | · | · | |
| Common Stock | $19M | $19M | $19M | $18M | $13M | |
| Paid-in Capital | $816M | $795M | $774M | $725M | $262M | |
| Retained Earnings | $-700M | $-551M | $-510M | $-358M | $-190M | |
| AOCI | $-18M | $-19M | $-22M | $-8M | $6M | |
| Stockholders' Equity | $116M | $243M | $261M | $377M | $91M | |
| Liabilities + Equity | $159M | $293M | $305M | $414M | $112M | |
| Shares Outstanding | 167,959,752 | 166,026,396 | 165,935,914 | 160,677,001 | 114,735,712 |
Cashflow 15
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| D&A | $473.0K | $319.0K | $168.0K | $47.0K | $24.0K | |
| Stock-based Comp | $25M | $33M | $42M | $63M | $67M | |
| Deferred Tax | · | $0 | $5M | $-5M | $0 | |
| Amort. of Intangibles | $200.0K | $200.0K | · | · | · | |
| Other Non-cash | $41M | $-77M | $301.0K | $46M | · | |
| Operating Cash Flow | $-82M | $-84M | $-104M | $-63M | $-21M | |
| CapEx | $6.0K | $259.0K | $773.0K | $173.0K | $59.0K | |
| Investing Cash Flow | $59M | $-53M | $-87M | $-81M | $-28M | |
| Stock Issued | · | · | $0 | $410M | $82M | |
| Stock Repurchased | · | · | · | $500.0K | · | |
| Net Stock Activity | · | · | $0 | $409M | · | |
| Financing Cash Flow | $5M | $-8M | $21M | $410M | $113M | |
| Net Change in Cash | $-18M | $-146M | $-172M | $265M | $67M | |
| Free Cash Flow | $-82M | $-84M | $-105M | $-63M | · | |
| Levered FCF | · | $-87M | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Margin | -33341.2% | -39958.9% | -62140.3% | -666.5% | · | |
| Net Margin | -48464.0% | -12810.2% | -65401.3% | -823.6% | · | |
| Pretax Margin | -48183.4% | -12511.5% | -58018.0% | -670.4% | · | |
| EBITDA Margin | -33187.7% | -39857.3% | -62068.2% | -666.3% | · | |
| ROA | -65.9% | -13.4% | -42.4% | -63.8% | · | |
| ROE | -83.1% | -16.0% | -47.8% | -71.8% | · | |
| ROIC | -61.2% | -36.5% | -44.1% | -35.0% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 9.2 | 14.4 | 17.9 | · | |
| Quick Ratio | 0.7 | 2.2 | 9.6 | 17.3 | · | |
| Debt / Equity | 0.4 | 0.4 | 0.3 | · | · | |
| Interest Coverage | · | -47.2 | · | · | · |
Effizienz 1
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | · |
Wachstumsraten 2
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue YoY | -1.9% | 34.8% | -98.9% | · | · | |
| Revenue CAGR 3Y | -75.3% | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue TTM | $308.0K | $314.0K | $233.0K | $20M | · | |
| Net Income TTM | $-149M | $-40M | $-152M | $-168M | · | |
| Market Cap | $223M | $234M | $441M | $1.23B | · | |
| Enterprise Value | $257M | $298M | $333M | · | · | |
| P/E | -1.4 | -5.6 | -2.7 | -6.3 | · | |
| P/S | 725.3 | 745.5 | 1894.4 | 60.2 | · | |
| P/B | 1.9 | 1.0 | 1.7 | 3.3 | · | |
| P / Tangible Book | 2.0 | 1.0 | 1.7 | 3.3 | · | |
| P / Cash Flow | -2.7 | -2.8 | -4.2 | -19.4 | · | |
| P / FCF | -2.7 | -2.8 | -4.2 | -19.3 | · | |
| EV / EBITDA | -2.5 | -2.4 | -2.3 | · | · | |
| EV / FCF | -3.1 | -3.5 | -3.2 | · | · | |
| EV / Revenue | 834.6 | 949.9 | 1430.4 | · | · | |
| Earnings Yield | -69.9% | -17.7% | -36.8% | -15.9% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $749.0K | $719.0K | $2M | $-5.0K | $40.0K | $273.0K | $0 | $18.0K | $87.0K | $172.0K | $37.0K | $39.0K | $24.0K | $170.0K | $0 | $230.0K | |
| SG&A Expense | $15M | $15M | $11M | $11M | $10M | $13M | $13M | $19M | $14M | $17M | $14M | $16M | $19M | $17M | $18M | $26M | |
| Operating Expenses | $29M | $26M | $22M | $30M | $23M | $26M | $24M | $34M | $27M | $32M | $33M | $38M | $38M | $36M | $33M | $45M | |
| Operating Income | $-28M | $-25M | $-20M | $-30M | $-23M | $-26M | $-24M | $-34M | $-27M | $-32M | $-33M | $-38M | $-38M | $-35M | $-33M | $-45M | |
| Interest Expense | · | · | · | · | · | $702.0K | $687.0K | · | $686.0K | $658.0K | $622.0K | $923.0K | $0 | $0 | $0 | · | |
| Interest Income | $504.0K | $248.0K | $186.0K | $193.0K | $160.0K | $118.0K | $307.0K | $657.0K | $612.0K | $303.0K | $275.0K | $188.0K | $145.0K | $117.0K | $98.0K | $125.0K | |
| Other Non-op | $-650.0K | $-752.0K | $0 | $2M | $-2M | $-667.0K | $-5.0K | $-90.0K | $-308.0K | $-34.0K | $243.0K | $-401.0K | $-100.0K | $12.0K | $0 | $-29.0K | |
| Pretax Income | $-61M | $-28M | $-26M | $-39M | $-26M | $-57M | $-26M | $-18M | $44M | $-32M | $-33M | $-39M | $-33M | $-31M | $-32M | $-49M | |
| Income Tax | $131.0K | $93.0K | $156.0K | $-193.0K | $-178.0K | $19.0K | $-4.0K | $428.0K | $238.0K | $185.0K | $165.0K | $6M | $135.0K | $51.0K | $41.0K | $4M | |
| Net Income | $-61M | $-28M | $-26M | $-39M | $-26M | $-57M | $-27M | $-18M | $44M | $-33M | $-33M | $-45M | $-34M | $-37M | $-37M | $-89M | |
| EPS (Basic) | $-0.28 | $-0.14 | $-0.15 | $-0.24 | $-0.16 | $-0.36 | $-0.17 | $-0.11 | $0.28 | $-0.21 | $-0.21 | $-0.28 | $-0.22 | $-0.24 | $-0.24 | $-0.64 | |
| EPS (Diluted) | $-0.28 | $-0.14 | $-0.15 | $-0.24 | $-0.16 | $-0.36 | $-0.17 | $-0.08 | $0.25 | $-0.21 | $-0.21 | $-0.28 | $-0.22 | $-0.24 | $-0.24 | $-0.64 | |
| Shares (Basic) | 217,601,496 | 196,563,699 | 176,271,176 | -319,740,602 | 160,621,817 | 160,387,701 | 158,891,067 | -308,543,685 | 155,792,490 | 155,792,490 | 155,792,490 | -308,388,353 | 156,607,468 | 153,971,202 | 153,529,268 | 3,931,174 | |
| Shares (Diluted) | 217,601,496 | 196,563,699 | 176,271,176 | -319,740,602 | 160,621,817 | 160,387,701 | 158,891,067 | -330,317,168 | 177,565,973 | 155,792,490 | 155,792,490 | -308,388,353 | 156,607,468 | 153,971,202 | 153,529,268 | -266,503,858 | |
| EBITDA | $-28M | $-25M | $-20M | · | $-23M | $-26M | $-24M | · | $-27M | $-32M | $-33M | · | $-38M | $-35M | $-33M | · |
Bilanz 27
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $62M | $48M | $18M | $30M | $19M | $19M | $45M | $76M | $141M | $186M | $191M | $143M | $84M | $124M | $362M | |
| Prepaid Expense | $6M | $7M | $8M | $8M | $7M | $5M | $6M | $6M | $7M | $6M | $9M | $14M | $13M | $11M | $13M | $12M | |
| Other Current Assets | $1M | $1M | $1M | $775.0K | $919.0K | $899.0K | $1M | $846.0K | $638.0K | $1M | $2M | $2M | $1M | $1M | $1M | $756.0K | |
| Current Assets | $131M | $103M | $116M | $80M | $114M | $118M | $118M | $186M | $216M | $243M | $268M | $287M | $317M | $324M | $349M | $375M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $865.0K | $873.0K | $920.0K | $981.0K | $992.0K | $1M | $1M | $928.0K | $728.0K | $303.0K | $178.0K | $149.0K | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | · | · | · | $1M | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $733.0K | $610.0K | $518.0K | $398.0K | · | · | · | $153.0K | · | · | · | · | · | · | · | · | |
| Goodwill | $331.0K | $331.0K | $331.0K | $331.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $3M | $3M | $3M | $3M | · | · | · | $2M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $382.0K | $389.0K | $810.0K | $850.0K | $2M | $2M | $3M | $948.0K | $3M | $3M | $3M | $3M | $9M | $8M | $8M | $7M | |
| Total Assets | $240M | $189M | $196M | $159M | $198M | $216M | $269M | $293M | $308M | $254M | $281M | $305M | $343M | $349M | $384M | $414M | |
| Accounts Payable | $5M | $4M | $3M | $3M | $5M | $4M | $4M | $5M | $6M | $4M | $5M | $2M | $4M | $3M | $4M | $6M | |
| Accrued Liabilities | $10M | $15M | $9M | $10M | $12M | $13M | $11M | $15M | $13M | $13M | $14M | $17M | $22M | $19M | $18M | $15M | |
| Short-term Debt | $84M | $34M | $50M | $45M | $56M | $69M | $87M | · | $132M | $86M | $64M | · | $162M | $228M | $211M | · | |
| Current Liabilities | $17M | $26M | $29M | $25M | $20M | $18M | $15M | $20M | $20M | $18M | $20M | $20M | $26M | $22M | $22M | $21M | |
| Capital Leases | $2M | $3M | $3M | $732.0K | $808.0K | $838.0K | $907.0K | $990.0K | $1M | $1M | $1M | $44.0K | $100.0K | $100.0K | $100.0K | · | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $8M | $8M | $8M | $8M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $80M | $45M | $44M | $43M | $51M | $47M | $46M | $49M | $40M | $38M | $40M | $40M | $47M | $29M | $29M | $28M | |
| Long-term Debt | $0 | $0 | $9M | $14M | $20M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | · | $0 | |
| Total Debt | $84M | $34M | $61M | · | $56M | $69M | $87M | · | $132M | $86M | $64M | · | $162M | $228M | $211M | · | |
| Common Stock | $27M | $24M | $22M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $18M | $18M | $18M | |
| Paid-in Capital | $969M | $895M | $876M | $816M | $808M | $803M | $801M | $795M | $799M | $792M | $783M | $774M | $762M | $746M | $735M | $725M | |
| Retained Earnings | $-815M | $-754M | $-727M | $-700M | $-661M | $-635M | $-578M | $-551M | $-533M | $-577M | $-544M | $-510M | $-465M | $-431M | $-395M | $-358M | |
| AOCI | $-21M | $-21M | $-19M | $-18M | $-20M | $-19M | $-19M | $-19M | $-19M | $-21M | $-21M | $-22M | $-26M | $-21M | $-13M | $-8M | |
| Stockholders' Equity | $160M | $144M | $152M | $116M | $146M | $168M | $223M | $243M | $266M | $213M | $237M | $261M | $289M | $312M | $346M | $377M | |
| Liabilities + Equity | $240M | $189M | $196M | $159M | $198M | $216M | $269M | $293M | $308M | $254M | $281M | $305M | $343M | $349M | $384M | $414M | |
| Shares Outstanding | 240,437,237 | 212,244,597 | 199,775,512 | 167,959,752 | 167,818,316 | 167,771,990 | 166,274,426 | 166,026,396 | 166,010,476 | 166,010,476 | 166,010,476 | 165,935,914 | 165,875,307 | 161,727,785 | 160,719,828 | 160,677,001 |
Cashflow 14
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $233.0K | $227.0K | $216.0K | $225.0K | $83.0K | $82.0K | $83.0K | $101.0K | $74.0K | $79.0K | $65.0K | $53.0K | $36.0K | $19.0K | $60.0K | $29.0K | |
| Stock-based Comp | $3M | $3M | $3M | $8M | $5M | $6M | $6M | $7M | $8M | $9M | $9M | $12M | $11M | $10M | $10M | $13M | |
| Amort. of Intangibles | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | $5M | · | · | · | $-2M | · | · | · | $3M | · | · | · | $3M | · | |
| Operating Cash Flow | $-23M | $-14M | $-18M | $-24M | $-19M | $-16M | $-23M | $-22M | $-18M | $-23M | $-21M | $-31M | $-28M | $-22M | $-24M | $-21M | |
| CapEx | $396.0K | $127.0K | $268.0K | $6.0K | $0 | $0 | $0 | $8.0K | $0 | $-29.0K | $280.0K | $142.0K | $459.0K | $116.0K | $56.0K | $52.0K | |
| Investing Cash Flow | $-68M | $10M | $-11M | $7M | $25M | $16M | $11M | $-823.0K | $-46M | $-22M | $16M | $80M | $66M | $-18M | $-215M | $-49M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $0 | $1M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | $-1M | · | · | · | $-1M | · | |
| Financing Cash Flow | $60M | $8M | $60M | $154.0K | $5M | $326.0K | $0 | $-8M | $0 | $-100.0K | $206.0K | $-922.0K | $20M | $2M | $132.0K | $2M | |
| Net Change in Cash | $-32M | $4M | $31M | $-17M | $11M | $465.0K | $-11M | $-31M | $-65M | $-45M | $-5M | $48M | $58M | $-40M | $-238M | $-68M | |
| Free Cash Flow | · | · | $-18M | · | · | · | $-23M | · | · | · | $-21M | · | · | · | $-24M | · | |
| Levered FCF | · | · | · | · | · | · | $-23M | · | · | · | $-22M | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3796.5% | -3515.0% | -1310.0% | · | -56505.0% | -9424.5% | · | · | -30843.7% | -18524.4% | -89767.6% | · | -160095.8% | -20798.2% | · | · | |
| Net Margin | -8154.1% | -3856.6% | -1699.7% | · | -65715.0% | -20993.4% | · | · | 50855.2% | -19210.5% | -89554.0% | · | -141195.8% | -21540.0% | · | · | |
| Pretax Margin | -8139.8% | -3846.0% | -1691.9% | · | -66157.5% | -20907.3% | · | · | 50398.8% | -18405.8% | -89610.8% | · | -138058.3% | -18121.2% | · | · | |
| EBITDA Margin | -3796.5% | -3515.0% | -1296.1% | · | -56505.0% | -9424.5% | · | · | -30843.7% | -18524.4% | -89591.9% | · | -160095.8% | -20798.2% | · | · | |
| ROA | -27.9% | -13.7% | -11.4% | · | -10.4% | -24.4% | -9.7% | · | 13.6% | -11.0% | -10.0% | · | -8.2% | -8.6% | -19.2% | · | |
| ROE | -40.0% | -17.8% | -14.1% | · | -12.8% | -30.1% | -11.6% | · | 15.9% | -12.6% | -11.4% | · | -9.1% | -9.3% | -21.3% | · | |
| ROIC | -11.7% | -14.3% | -9.6% | · | -11.1% | -10.9% | -7.8% | · | -6.7% | -10.7% | -11.1% | · | -8.6% | -6.6% | -6.0% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 4.0 | 4.1 | · | 5.8 | 6.7 | 7.8 | · | 11.0 | 13.5 | 13.4 | · | 12.3 | 14.7 | 15.8 | · | |
| Quick Ratio | 1.8 | 2.4 | 1.7 | · | 1.5 | 1.1 | 1.3 | · | 3.9 | 7.9 | 9.3 | · | 5.5 | 3.8 | 5.6 | · | |
| Debt / Equity | 0.5 | 0.2 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | |
| Interest Coverage | · | · | · | · | · | -36.7 | -35.1 | · | -39.1 | -48.4 | -53.4 | · | · | · | · | · |
Effizienz 1
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | $2M | · | $400.0K | $532.0K | $296.0K | · | $320.0K | $403.0K | $231.0K | · | $460.0K | $436.0K | $20M | · | |
| Net Income TTM | $-142M | $-138M | $-137M | · | $-66M | $-73M | $-49M | · | $-56M | $-137M | $-141M | · | $-139M | $-153M | $-116M | · | |
| Market Cap | $1.27B | $465M | $272M | · | $195M | $223M | $328M | · | $214M | $286M | $300M | · | $549M | $589M | $818M | · | |
| Enterprise Value | $1.33B | $437M | $285M | · | $221M | $273M | $396M | · | $270M | $231M | $179M | · | $568M | $733M | $905M | · | |
| P/E | -7.2 | -2.7 | -1.6 | · | -2.6 | -2.7 | -5.8 | · | -3.3 | -2.0 | -2.0 | · | -3.6 | -3.4 | -6.3 | · | |
| P/S | 415.3 | 179.7 | 145.4 | · | 486.7 | 419.4 | 1106.6 | · | 669.2 | 708.5 | 1300.8 | · | 1193.6 | 1350.2 | 40.6 | · | |
| P/B | 8.0 | 3.2 | 1.8 | · | 1.3 | 1.3 | 1.5 | · | 0.8 | 1.3 | 1.3 | · | 1.9 | 1.9 | 2.4 | · | |
| P / Tangible Book | 8.1 | 3.3 | 1.8 | · | 1.3 | 1.3 | 1.5 | · | 0.8 | 1.3 | 1.3 | · | 1.9 | 1.9 | 2.4 | · | |
| P / Cash Flow | · | · | -15.2 | · | · | · | -14.5 | · | · | · | -14.2 | · | · | · | -34.1 | · | |
| P / FCF | · | · | -15.0 | · | · | · | -14.5 | · | · | · | -14.0 | · | · | · | -34.0 | · | |
| EV / EBITDA | -46.6 | -17.3 | -14.1 | · | -9.8 | -10.6 | -16.5 | · | -10.1 | -7.2 | -5.4 | · | -14.8 | -20.7 | -27.1 | · | |
| EV / FCF | · | · | -15.7 | · | · | · | -17.5 | · | · | · | -8.3 | · | · | · | -37.6 | · | |
| EV / Revenue | 432.8 | 168.9 | 152.4 | · | 551.8 | 512.8 | 1338.2 | · | 844.3 | 572.8 | 773.1 | · | 1234.8 | 1681.1 | 44.9 | · | |
| Earnings Yield | -13.8% | -37.0% | -61.8% | · | -37.9% | -36.8% | -17.3% | · | -30.2% | -51.2% | -50.3% | · | -27.5% | -29.1% | -15.9% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $308.0K | $314.0K | $233.0K | $20M | $0 |
| Betriebsgewinnmarge % | -33341.2% | -39958.9% | -62140.3% | -666.5% | — |
| Nettoergebnis | $-149M | $-40M | $-152M | $-168M | $-170M |
| Verwässerte EPS | $-0.93 | $-0.25 | $-0.98 | $-1.21 | — |
Bilanz
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.4 | 0.3 | — | — |
| Liquiditätsgrad | 3.2 | 9.2 | 14.4 | 17.9 | — |
| Quick Ratio | 0.7 | 2.2 | 9.6 | 17.3 | — |
Cashflow
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-82M | $-84M | $-105M | $-63M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- The market for psychedelic drugs to treat mental health conditions gets a big buy signal
- Eli Lilly to Pay up to $3.8B for AtaiBeckley in Big Pharma’s Latest Psychedelic Foray
- AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly
- Eli Lilly kauft AtaiBeckley für 2,8 Mrd. Dollar – Was das für die LLY-Aktie bedeutet
- Warum AtaiBeckley-Aktie heute gestiegen ist
- AtaiBeckley mit „Buy“-Rating von Deutsche Bank Analysten in Erstabdeckung bewertet
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 251 Einreicher · $489.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 90 | 20 | 78 | 28 | — |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen. Änderung gegenüber Vorquartal nicht angezeigt: Die Einreicherabdeckung unterscheidet sich zwischen diesen beiden Quartalen zu stark für einen zuverlässigen Vergleich.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Deep Track Capital, LP | $75.979.919 | 14.417.442 | 15,51% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $61.908.002 | 11.747.249 | 12,64% | Aktien |
| STATE STREET CORP | $43.672.775 | 8.287.054 | 8,92% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $31.818.455 | 6.036.743 | 6,50% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $29.737.335 | 5.642.758 | 6,07% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.640.992 | 4.106.450 | 4,42% | Aktien |
| Candriam S.C.A. | $16.002.222 | 3.039.399 | 3,27% | Aktien |
| Foresite Capital Management VI LLC | $14.492.500 | 2.750.000 | 2,96% | Aktien |
| RTW INVESTMENTS, LP | $10.540.000 | 2.000.000 | 2,15% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.359.149 | 1.965.683 | 2,12% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.330.672 | 1.770.526 | 1,91% | Aktien |
| Eagle Health Investments LP | $9.008.322 | 1.709.359 | 1,84% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $8.307.080 | 1.576.296 | 1,70% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.129.502 | 1.542.600 | 1,66% | Kaufoption |
| Halter Ferguson Financial Inc. | $7.829.060 | 1.485.590 | 1,60% | Aktien |
| FIRST TRUST ADVISORS LP | $7.248.885 | 1.375.500 | 1,48% | Aktien |
| Newtyn Management, LLC | $6.259.748 | 1.187.808 | 1,28% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $5.019.043 | 952.380 | 1,02% | Aktien |
| ADAR1 Capital Management, LLC | $4.812.785 | 913.242 | 0,98% | Aktien |
| AdvisorShares Investments LLC | $4.652.841 | 882.892 | 0,95% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.384.002 | 831.879 | 0,90% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.334.422 | 822.471 | 0,88% | Aktien |
| ORBIMED ADVISORS LLC | $4.202.825 | 797.500 | 0,86% | Aktien |
| Brown University | $3.786.495 | 718.500 | 0,77% | Aktien |
| Woodline Partners LP | $3.162.000 | 600.000 | 0,65% | Aktien |
| CITADEL ADVISORS LLC | $2.863.539 | 543.366 | 0,58% | Aktien |
| JGP Global Gestao de Recursos Ltda. | $2.635.000 | 500.000 | 0,54% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $2.580.261 | 489.613 | 0,53% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.569.051 | 487.486 | 0,52% | Aktien |
| Amova Asset Management Americas, Inc. | $2.545.588 | 483.952 | 0,52% | Aktien |
| Swiss National Bank | $2.496.399 | 473.700 | 0,51% | Aktien |
| RHUMBLINE ADVISERS | $2.105.019 | 399.436 | 0,43% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.008.529 | 381.125 | 0,41% | Aktien |
| Man Group plc | $1.890.939 | 358.812 | 0,39% | Aktien |
| Bank of New York Mellon Corp | $1.743.537 | 330.842 | 0,36% | Aktien |
| BIT Capital GmbH | $1.689.436 | 320.576 | 0,34% | Aktien |
| BlackRock, Inc. | $1.557.628 | 295.565 | 0,32% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.525.707 | 289.508 | 0,31% | Aktien |
| Jefferies Financial Group Inc. | $1.453.993 | 275.900 | 0,30% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.424.481 | 270.300 | 0,29% | Verkaufsoption |
| Warm Springs Advisors Inc. | $1.386.010 | 263.000 | 0,28% | Aktien |
| CenterBook Partners LP | $1.352.403 | 256.623 | 0,28% | Aktien |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $1.332.852 | 252.913 | 0,27% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.263.851 | 239.820 | 0,26% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.258.470 | 355.500 | 0,26% | Aktien |
| CITADEL ADVISORS LLC | $1.180.480 | 224.000 | 0,24% | Kaufoption |
| CITIGROUP INC | $1.164.986 | 221.060 | 0,24% | Aktien |
| Catalio Capital Management, LP | $1.037.442 | 196.858 | 0,21% | Aktien |
| Boussard & Gavaudan Investment Management LLP | $1.034.900 | 295.264 | 0,21% | Aktien |
| Rockefeller Capital Management L.P. | $996.030 | 189.000 | 0,20% | Aktien |
| MetLife Investment Management, LLC | $994.323 | 188.676 | 0,20% | Aktien |
| Burkehill Global Management, LP | $974.950 | 185.000 | 0,20% | Aktien |
| CITADEL ADVISORS LLC | $951.762 | 180.600 | 0,19% | Verkaufsoption |
| STABLEFORD CAPITAL II LLC | $887.205 | 168.350 | 0,18% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $876.480 | 166.315 | 0,18% | Aktien |
| MORGAN STANLEY | $813.193 | 154.306 | 0,17% | Aktien |
| AXON CAPITAL LP | $805.804 | 152.904 | 0,16% | Aktien |
| Diametric Capital, LP | $783.659 | 148.702 | 0,16% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $774.221 | 146.911 | 0,16% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $768.366 | 145.800 | 0,16% | Aktien |
| BARCLAYS PLC | $763.866 | 144.946 | 0,16% | Aktien |
| Carrera Capital Advisors | $724.941 | 137.560 | 0,15% | Aktien |
| TWO SIGMA ADVISERS, LP | $720.658 | 176.200 | 0,15% | Aktien |
| JANE STREET GROUP, LLC | $674.560 | 128.000 | 0,14% | Kaufoption |
| Invesco Ltd. | $673.348 | 127.770 | 0,14% | Aktien |
| NewEdge Advisors, LLC | $638.281 | 121.116 | 0,13% | Aktien |
| LPL Financial LLC | $620.153 | 117.676 | 0,13% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $585.961 | 111.188 | 0,12% | Aktien |
| MARSHALL WACE, LLP | $579.799 | 110.019 | 0,12% | Aktien |
| MYDA Advisors LLC | $579.700 | 110.000 | 0,12% | Aktien |
| Lighthouse Investment Partners, LLC | $545.023 | 103.420 | 0,11% | Aktien |
| Eversept Partners, LP | $539.806 | 102.430 | 0,11% | Aktien |
| Verdad Advisers, LP | $530.589 | 100.681 | 0,11% | Aktien |
| JPMORGAN CHASE & CO | $524.326 | 83.626 | 0,11% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $497.999 | 94.497 | 0,10% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $494.853 | 93.900 | 0,10% | Aktien |
| Z3 Capital Partners, LLC | $487.607 | 92.525 | 0,10% | Aktien |
| EntryPoint Capital, LLC | $455.839 | 86.497 | 0,09% | Aktien |
| VANGUARD GROUP INC | $451.912 | 110.492 | 0,09% | Aktien |
| Virtus Investment Advisers, LLC | $439.882 | 83.469 | 0,09% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $431.671 | 81.911 | 0,09% | Aktien |
| GOLDMAN SACHS GROUP INC | $421.600 | 80.000 | 0,09% | Kaufoption |
| State of New Jersey Common Pension Fund D | $402.301 | 76.338 | 0,08% | Aktien |
| Vontobel Holding Ltd. | $399.877 | 75.878 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $397.579 | 75.442 | 0,08% | Aktien |
| TRUIST FINANCIAL CORP | $395.672 | 75.080 | 0,08% | Aktien |
| PROFUND ADVISORS LLC | $387.861 | 73.598 | 0,08% | Aktien |
| China Universal Asset Management Co., Ltd. | $380.352 | 72.173 | 0,08% | Aktien |
| WINTON GROUP Ltd | $372.062 | 70.600 | 0,08% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $355.488 | 67.455 | 0,07% | Aktien |
| SEI INVESTMENTS CO | $348.136 | 66.060 | 0,07% | Aktien |
| Nuveen, LLC | $348.136 | 66.060 | 0,07% | Aktien |
| Vanguard Investments Australia, Ltd. | $346.223 | 65.697 | 0,07% | Aktien |
| ARIZONA STATE RETIREMENT SYSTEM | $343.309 | 65.144 | 0,07% | Aktien |
| STRS OHIO | $330.956 | 62.800 | 0,07% | Aktien |
| Squarepoint Ops LLC | $330.281 | 62.672 | 0,07% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $327.167 | 62.081 | 0,07% | Aktien |
| HighTower Advisors, LLC | $324.859 | 61.643 | 0,07% | Aktien |
| Walleye Capital LLC | $321.470 | 61.000 | 0,07% | Verkaufsoption |
| Walleye Capital LLC | $320.511 | 60.818 | 0,07% | Aktien |
Unternehmensinsider 23 Insider · 11 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Srinivas Rao | Co-Founder and Chief Executive Officer | 13. August 2025 A | 212.942 | 0 | 0 | $0 |
| Florian Brand | Co-Founder & Co-Chief Executive Officer | 4. Oktober 2024 A | 328.697 | 0 | 0 | $0 |
| Anne Nagengast Johnson | Chief Financial Officer | 21. März 2025 S | 140.045 | 0 | 0 | $0 |
| Stephen Bardin | Chief Financial Officer | 14. März 2023 A | — | 0 | 0 | $0 |
| Gregory L Weaver | Chief Financial Officer | 2. März 2022 A | 4.666 | 0 | 0 | $0 |
| Gerd Kochendoerfer | Chief Operating Officer | 2. Januar 2025 A | — | 0 | 0 | $0 |
| Christopher Ryan Cave Barrett | Chief Legal and Business Officer | 1. Oktober 2025 A | — | 0 | 0 | $0 |
| Kevin James Craig | Chief Medical Officer | 21. März 2025 S | 8.437 | 0 | 0 | $0 |
| Glenn Frank Short | Chief Scientific Officer | 21. März 2025 S | 42.333 | 0 | 0 | $0 |
| Sahil Kirpekar | Chief Business Officer | 21. März 2025 S | 115.636 | 0 | 0 | $0 |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | 14. März 2023 A | — | 0 | 0 | $0 |
| Cosmo Feilding-Mellen | Direktor | 25. November 2025 A | 7.702.990 | 0 | 0 | $0 |
| Robert Hershberg | Direktor | 5. November 2025 A | — | 0 | 0 | $0 |
| Scott Braunstein | Direktor | 4. November 2025 A | — | 0 | 0 | $0 |
| John Francis Hoffman | Direktor | 26. Juni 2025 A | — | 0 | 0 | $0 |
| Christian Angermayer | Direktor | 26. Juni 2025 A | 20.185.200 | 0 | 0 | $0 |
| Andrea Heslin Smiley | Direktor | 26. Juni 2025 A | 4.666 | 0 | 0 | $0 |
| Amir H Kalali | Direktor | 26. Juni 2025 A | 4.666 | 0 | 0 | $0 |
| Laurent Fischer | Direktor | 26. Juni 2025 A | — | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Direktor | 26. Juni 2025 A | — | 0 | 0 | $0 |
| Michael Auerbach | Direktor | 13. Juni 2024 A | 0 | 0 | 0 | $0 |
| Jason Camm | Direktor | 23. Mai 2023 A | — | 0 | 0 | $0 |
| Alexis De Rosnay | Direktor | 25. Mai 2022 A | 4.666 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V., ATAI Life Sciences GmbH (formerly ATAI Life Sciences AG) ×8 Einreichungen | 29. Oktober 2025 | 6,00% | Änderung | — | SEC |
| Apeiron Investment Group Ltd., Apeiron Presight Capital Fund II, L.P., Presight Capital Management I, L.L.C., Fabian Hansen, Christian Angermayer ×4 Einreichungen | 20. Oktober 2025 | 24,00% | Änderung | — | SEC |
| ATAI Life Sciences BV, ATAI Life Sciences AG | 24. Mai 2021 | — | Erste Einreichung | — | SEC |
| ATAI Life Sciences B.V., ATAI Life Sciences AG | 24. Mai 2021 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 32 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,48% | 4.382.604 NS | 30. April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,72% | 64.337 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,39% | 970.943 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 0,31% | 697.691 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,18% | 20.039 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,16% | 2.161.232 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,12% | 2.552.242 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 303.809 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,08% | 13.429 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 90.536 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 8.094.723 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 195.590 NS | 30. April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 112.661 NS | 30. April 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,06% | 178.479 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.843.437 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,04% | 42.142 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,03% | 13.740 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,03% | 35.248 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 710.419 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 938.433 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 358.044 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 16.197 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 54.067 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 75.711 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.261.092 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 32.184 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 112.544 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 84.933 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 315.073 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 133.130 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.192.000 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.630 SH | 8. August 2026 | Täglich |